IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Integrated Biopharma Inc (INBP)

Q2 2025 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Moloney Securities Asset Management, LLC
UNCHANGED
Shares20,000 from 20,000
Change0 (0%)
Value$5.8K (-$1.3K)
Filed 2025-11-05
Status
Moloney Securities Asset Management, LLC
UNCHANGED20,00020,00000%$7.1K$5.8K-$1.3K2025-11-05
Showing 1 of 1 institutions